These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 25294366)

  • 1. Pathogenesis of Middle East respiratory syndrome coronavirus.
    van den Brand JM; Smits SL; Haagmans BL
    J Pathol; 2015 Jan; 235(2):175-84. PubMed ID: 25294366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathology of emerging coronavirus infections.
    Gralinski LE; Baric RS
    J Pathol; 2015 Jan; 235(2):185-95. PubMed ID: 25270030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.
    Rockx B; Kuiken T; Herfst S; Bestebroer T; Lamers MM; Oude Munnink BB; de Meulder D; van Amerongen G; van den Brand J; Okba NMA; Schipper D; van Run P; Leijten L; Sikkema R; Verschoor E; Verstrepen B; Bogers W; Langermans J; Drosten C; Fentener van Vlissingen M; Fouchier R; de Swart R; Koopmans M; Haagmans BL
    Science; 2020 May; 368(6494):1012-1015. PubMed ID: 32303590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad-spectrum coronavirus antiviral drug discovery.
    Totura AL; Bavari S
    Expert Opin Drug Discov; 2019 Apr; 14(4):397-412. PubMed ID: 30849247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.
    Nascimento Junior JAC; Santos AM; Quintans-Júnior LJ; Walker CIB; Borges LP; Serafini MR
    Expert Opin Ther Pat; 2020 Aug; 30(8):567-579. PubMed ID: 32429703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.
    Liu J; Zheng X; Tong Q; Li W; Wang B; Sutter K; Trilling M; Lu M; Dittmer U; Yang D
    J Med Virol; 2020 May; 92(5):491-494. PubMed ID: 32056249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronaviruses: severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus in travelers.
    Al-Tawfiq JA; Zumla A; Memish ZA
    Curr Opin Infect Dis; 2014 Oct; 27(5):411-7. PubMed ID: 25033169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19.
    Halaji M; Farahani A; Ranjbar R; Heiat M; Dehkordi FS
    Infez Med; 2020 Jun; 28(suppl 1):6-17. PubMed ID: 32532933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From SARS and MERS CoVs to SARS-CoV-2: Moving toward more biased codon usage in viral structural and nonstructural genes.
    Kandeel M; Ibrahim A; Fayez M; Al-Nazawi M
    J Med Virol; 2020 Jun; 92(6):660-666. PubMed ID: 32159237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Middle East Respiratory Syndrome Virus Pathogenesis.
    Singh SK
    Semin Respir Crit Care Med; 2016 Aug; 37(4):572-7. PubMed ID: 27486737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From SARS to MERS, Thrusting Coronaviruses into the Spotlight.
    Song Z; Xu Y; Bao L; Zhang L; Yu P; Qu Y; Zhu H; Zhao W; Han Y; Qin C
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30646565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of SARS/MERS CoV to interferons and other drugs based on achievable serum concentrations in humans.
    Strayer DR; Dickey R; Carter WA
    Infect Disord Drug Targets; 2014; 14(1):37-43. PubMed ID: 25019238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS and MERS: recent insights into emerging coronaviruses.
    de Wit E; van Doremalen N; Falzarano D; Munster VJ
    Nat Rev Microbiol; 2016 Aug; 14(8):523-34. PubMed ID: 27344959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-A possible reference for coronavirus disease-19 treatment option.
    Yao TT; Qian JD; Zhu WY; Wang Y; Wang GQ
    J Med Virol; 2020 Jun; 92(6):556-563. PubMed ID: 32104907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of animal models against emerging coronaviruses: From SARS to MERS coronavirus.
    Sutton TC; Subbarao K
    Virology; 2015 May; 479-480():247-58. PubMed ID: 25791336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What are our pharmacotherapeutic options for MERS-CoV?
    Al-Tawfiq JA; Memish ZA
    Expert Rev Clin Pharmacol; 2014 May; 7(3):235-8. PubMed ID: 24580083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous detection of severe acute respiratory syndrome, Middle East respiratory syndrome, and related bat coronaviruses by real-time reverse transcription PCR.
    Noh JY; Yoon SW; Kim DJ; Lee MS; Kim JH; Na W; Song D; Jeong DG; Kim HK
    Arch Virol; 2017 Jun; 162(6):1617-1623. PubMed ID: 28220326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis, treatment, control and prevention of SARS-CoV-2 and coronavirus disease 2019: back to the future].
    Ye ZW; Jin DY
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):571-592. PubMed ID: 32347053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview.
    Rabaan AA; Al-Ahmed SH; Haque S; Sah R; Tiwari R; Malik YS; Dhama K; Yatoo MI; Bonilla-Aldana DK; Rodriguez-Morales AJ
    Infez Med; 2020 Ahead Of Print Jun 1; 28(2):174-184. PubMed ID: 32275259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.